{
  "meta": {
    "title": "45_Biochemistry_Neet_2024",
    "url": "https://brainandscalpel.vercel.app/45-biochemistry-neet-2024-76eefe7b.html",
    "scrapedAt": "2025-11-30T12:58:00.189Z"
  },
  "questions": [
    {
      "text": "A patient underwent gastrectomy for gastric adenocarcinoma. Which of the following vitamins needs to be supplemented in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Vitamin B12\t"
        },
        {
          "id": 2,
          "text": "Vitamin B1"
        },
        {
          "id": 3,
          "text": "Vitamin A\t"
        },
        {
          "id": 4,
          "text": "Vitamin D"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>A patient who has undergone<strong> gastrectomy</strong> for gastric adenocarcinoma needs to be supplemented with <strong>vitamin B12.</strong></p>\n<p><strong>Vitamin B12 absorption</strong> is a complex process that relies on several factors. <strong>Intrinsic factor</strong>, a glycoprotein secreted by the <strong>parietal cells</strong> in the <strong>stomach</strong>, is essential for this process. <strong>Gastric acid</strong> and <strong>pepsin</strong> release vitamin B12 from dietary proteins, allowing it to bind with <strong>cobalophilin</strong> in the saliva. In the jejunum, cobalophilin is broken down, freeing vitamin B12 to bind with intrinsic factor. This complex is then <strong>absorbed</strong> in the <strong>distal ileum</strong> through specific receptors.  Following <strong>gastrectomy</strong>, the <strong>production</strong> of <strong>intrinsic factor</strong> is <strong>impaired</strong> due to the removal of gastric tissue, making vitamin B12 absorption difficult. Therefore, <strong>vitamin B12 supplementation</strong> is necessary after gastrectomy to <strong>prevent deficiency</strong>.</p>\n<p>Other<strong> complications </strong>of <strong>gastrectomy </strong>include:</p>\n<ul>\n<li>Nutritional deficiencies- <strong>Iron deficiency anemia (most common), Vitamin B12 deficiency</strong>, and osteoporosis</li>\n<li>Dumping syndrome: early and late</li>\n<li>Diarrhea</li>\n<li>Duodenal stump leak/blow out</li>\n<li>Bile reflux gastritis and esophagitis</li>\n<li>Gall stones</li>\n<li>Roux syndrome</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6568",
      "difficulty": "easy"
    },
    {
      "text": "A 10-year-old child from a southern Indian state, hailing from a poor family, presents with rough and scaly skin. The child’s diet lacks vegetables and fruits. After treatment with linseed oil, Vitamin A, and Vitamin B, the symptoms subsided. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Lichen planus\t"
        },
        {
          "id": 2,
          "text": "Erythroderma\t"
        },
        {
          "id": 3,
          "text": "Phrynoderma\t"
        },
        {
          "id": 4,
          "text": "Keratosis pilaris"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The cutaneous lesions with rough and scaly skin, with dietary history stating lack of vegetables and fruits is suggestive of <strong>phrynoderma.</strong></p>\n<p>Phrynoderma are <strong>keratotic follicular papules</strong> commonly present over the <strong>elbows</strong> and <strong>knees</strong>. They can also extend to the shoulders, neck, back, thighs, buttocks, and abdomen. It is also known as <strong>toad skin,</strong> due to the <strong>rough cone-shaped</strong> elevated papules. It can caused by deficiency of<strong> vitamins A, B complex, C</strong>, and <strong>E </strong>and <strong>essential fatty acids</strong>. </p>\n<p>When it occurs due to <strong>vitamin A deficiency</strong>, it is associated with ophthalmic symptoms like <strong>xerophthalmia</strong>, <strong>night blindness</strong>, and <strong>Bitot's spots </strong>and cutaneous symptoms like <strong>xerosis</strong>, <strong>scaling</strong>, and <strong>acne</strong>.</p>\n<p><strong>Management</strong> includes nutritional improvement through diet, <strong>multivitamin supplementation</strong>, and treatment of the underlying cause.</p>\n<p>Note: <strong>Linseed oil</strong> is rich in <strong>alpha-linolenic acid</strong>, which is an <strong>essential fatty acid</strong>.</p>\n<p>The toad skin appearance of a child with phrynoderma is given below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e487fa61df854ab7894ce2b5d0d63010x720x434.PNG\" alt=\"Explanation Image\"><p>Other options: </p>\n<p>Option A: Lichen planus is a <strong>papulosquamous</strong> lesion presenting as <strong>pruritic, purple, polygonal, planar, papules</strong> and <strong>plaques.</strong> These papules are often highlighted by white dots or lines called <strong>Wickham striae,</strong> which are created by areas of <strong>hypergranulosis. </strong>The characteristic lesions in <strong>lichen planus</strong> are shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/22f1a7f935d44bc68f7fe39709fd1971x1280x1187.JPEG\" alt=\"Explanation Image\"><p>Option B: <strong>Erythroderma</strong> is a serious skin condition characterized by <strong>widespread redness</strong> (erythema) and scaling affecting more than <strong>90%</strong> of the <strong>body's surface area.</strong> It is also known as <strong>exfoliative dermatitis</strong> and often results from <strong>underlying skin disorders, systemic diseases,</strong> or <strong>drug reactions.</strong></p>\n<p>Option D: <strong>Keratosis pilaris</strong> is an inherited abnormality of <strong>keratinization.</strong> It affects the follicular orifices leading to <strong>keratotic follicular plugging, perifollicular erythema,</strong> and <strong>follicular atrophy.</strong> It usually occurs during puberty. They present as <strong>small, keratotic papules</strong> on the extensor aspects of the limbs, particularly the arms which can lead to ingrowing of the hair. Treatment is purely reserved for cosmetic purposes. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b29c313687194d5ab1b4de38e3193a12x1280x1237.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Fat-soluble vitamins</h3><table>\n<tbody>\n<tr>\n<td rowspan=\"2\"><strong>Vitamin</strong></td>\n<td rowspan=\"2\"><strong>Active form</strong></td>\n<td rowspan=\"2\"><strong>Deficiency</strong></td>\n<td rowspan=\"2\"><strong>Toxicity</strong></td>\n<td colspan=\"3\"><strong>Required dietary allowance</strong></td>\n</tr>\n<tr>\n<td>Children</td>\n<td>Male</td>\n<td>Female</td>\n</tr>\n<tr>\n<td>Vitamin A</td>\n<td>\n<p>Retinol</p>\n<p>Retinal</p>\n<p>Retinoic acid</p>\n</td>\n<td>\n<p>Night blindness, xerophthalmia,</p>\n<p>Acne, psoriasis,</p>\n<p>Impaired immunity</p>\n</td>\n<td>\n<p>Affects lysosomes</p>\n<p>Acute- pseudotumor cerebrii, exfoliative dermatitis</p>\n<p>Chronic-fractures</p>\n</td>\n<td>\n<p>390-630mcg (1-9 years)</p>\n<p>770-1000mcg (10-18 years)</p>\n</td>\n<td>1000mcg&nbsp;</td>\n<td>&nbsp;\n<p>Adult - 840mcg</p>\n<p>Pregnancy - 900mcg</p>\n<p>Lactation - 950 mcg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin D</td>\n<td>1,25-Dihydro-cholecalciferol</td>\n<td>\n<p>Children- Rickets</p>\n<p>Adults-osteomalacia</p>\n</td>\n<td>Calcinosis</td>\n<td>&nbsp;\n<p>400 IU (&lt;1 year)</p>\n<p>600 IU (&gt;1 year)</p>\n</td>\n<td>&nbsp;600 IU</td>\n<td>\n<p>Adult - 600 IU</p>\n<p>Pregnancy - 600 IU</p>\n<p>Lactation - 600 IU</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin E</td>\n<td>&alpha;-tocopherol</td>\n<td>\n<p>Hemolytic anemia,</p>\n<p>axonal degeneration,</p>\n<p>spinocerebellar ataxia</p>\n</td>\n<td>\n<p>Reduced platelet aggregation,&nbsp;</p>\n<p>Interferes with vitamin K</p>\n</td>\n<td>&nbsp;5-8 mg</td>\n<td>&nbsp;10 mg</td>\n<td>\n<p>Adult - 8 mg</p>\n<p>Pregnancy - 10 mg</p>\n<p>Lactation - 12 mg</p>\n</td>\n</tr>\n<tr>\n<td>Vitamin K</td>\n<td>\n<p>Menedione</p>\n<p>Menoquinone</p>\n<p>Phyloquinone</p>\n</td>\n<td>\n<p>Elevated prothrombin time and bleeding</p>\n<p>Haemorrhagic disease of newborn</p>\n</td>\n<td>\n<p>Hemolysis</p>\n<p>Hyperbilirubinemia</p>\n<p>Kernicterus</p>\n</td>\n<td>\n<p>&lt;1 year - 2-3&nbsp;&micro;g</p>\n<p>Children - 30-50&nbsp;&micro;g</p>\n&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n<td>55 &micro;g&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note:The <strong>RDA</strong> for <strong>Vitamin D</strong> in the <strong>elderly</strong> (&gt;60 years) is <strong>800 IU</strong>.</p><hr><h3>Related Pearl: Vitamin-A supplementation & treatment of Vitamin-A deficiency</h3><table>\n<tbody>\n<tr>\n<td colspan=\"3\">\n<div><strong>Vitamin A supplementation</strong></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Target group</strong></div>\n</td>\n<td>\n<div>6 to 11 months age</div>\n</td>\n<td>\n<div>12 to 59 month of age (1yr to 5yr)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Dose</strong></div>\n</td>\n<td>\n<div>100,000 IU (oral)</div>\n</td>\n<td>\n<div>200,000 IU (oral)</div>\n</td>\n</tr>\n<tr>\n<td>\n<div><strong>Frequency</strong></div>\n</td>\n<td>\n<div>Once</div>\n</td>\n<td>\n<div>Every 4&ndash;6 months</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note</strong>: A total dose of&nbsp;<strong>17 lakh IU</strong> given as per the following schedule:</p>\n<ul>\n<li>100,000 IU is given with measles vaccine at 9 months</li>\n<li>200,000 IU is given with DPT booster at 15&ndash;18 months</li>\n<li>200,000 IU is given every 6 months (till 5years of age)</li>\n</ul>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"4\"><strong>Treatment </strong>of vitamin A<strong> deficiency</strong></td>\n</tr>\n<tr>\n<td><strong>Age</strong></td>\n<td>&lt; 6 months</td>\n<td>6-12 months</td>\n<td>&gt; 1 year</td>\n</tr>\n<tr>\n<td><strong>Dose</strong></td>\n<td>50,000 IU</td>\n<td>100,000 IU</td>\n<td>200,000 IU</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p><strong>Note:</strong> Route of administration is <strong>oral</strong>, in the form of retinyl palmitate.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6583",
      "difficulty": "easy"
    },
    {
      "text": "A  patient presents to the emergency department with severe abdominal pain, nausea, and vomiting. The laboratory results show serum triglyceride levels > 2000 mg/dl. Which deficiency could be contributing to the patient's condition?<div class='question-desc-html'><p>VLDL- very low density lipoprotein<br /><span>LDL- low density lipoprotein<br /></span>HDL- high density lipoprotein</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Apolipoprotein C II \t"
        },
        {
          "id": 2,
          "text": "Apolipoprotein B48\t"
        },
        {
          "id": 3,
          "text": "Apolipoprotein B100\t"
        },
        {
          "id": 4,
          "text": "Apolipoprotein A I "
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>elevated triglyceride levels </strong>and symptoms of <strong>acute pancreatitis</strong> are likely related to a <strong>deficiency</strong> in <strong>apolipoprotein C II</strong>.</p>\n<p>Apolipoprotein C2 is a <strong>lipoprotein lipase</strong> cofactor that catalyzes cleavage of chylomicrons. Defective apo C II results in <strong>type I hyperlipoproteinemia/ familial lipoprotein lipase deficiency</strong>. The resulting inactive lipoprotein lipase leads to<strong> slow clearance</strong> of <strong>chylomicrons</strong> and <strong>VLDL</strong>, and <strong>low levels</strong> of <strong>LDL </strong>and<strong> HDL</strong>. Patients present with <strong>eruptive xanthomas</strong> and <strong>acute pancreatitis</strong>.</p>\n<p><strong>Lipoprotein lipase</strong> is an extracellular enzyme that is present in the <strong>capillary walls </strong>of most tissues. It is chiefly <strong>synthesized</strong> by the <strong>adipose tissue</strong>, and <strong>cardiac</strong> and <strong>skeletal muscles</strong>. A deficiency of lipoprotein lipase or apo C-II leads to type 1 hyperlipoproteinemia or <strong>familial chylomicronemia</strong> which leads to an <strong>increased risk </strong>of <strong>acute pancreatitis</strong>.</p>\n<p>Other options:</p>\n<p>Option B: <strong>Apo B48</strong> is involved in the <strong>assembly</strong> of <strong>chylomicrons</strong>. Defects in this protein are not associated with familial hypercholesterolemia.</p>\n<p>Option C: <strong>Apo B100</strong> binds <strong>low-density lipoprotein receptors</strong>. For the <strong>uptake</strong> of <strong>LDL</strong>, apo B100 acts as a <strong>ligand</strong> for the low-density lipoprotein receptor.</p>\n<p>Option D: <strong>Apo A1</strong> activates<strong> lecithin cholesterol acyltransferase (LCAT)</strong>. LCAT is the enzyme <strong>present </strong>in<strong> HDL</strong>, which is activated by apo A1. LCAT converts <strong>free cholesterol </strong>(amphipathic) in HDL to <strong>cholesterol ester</strong>(hydrophobic). The initial <strong>discoidal</strong> shape now becomes <strong>spherical</strong>. This facilitates <strong>reverse cholesterol transport</strong>.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6586",
      "difficulty": "medium"
    },
    {
      "text": "After the age of 12, the boy had an intellectual disability. On examination, fingernail abrasions, excessive biting of lips, and increased levels of serum uric acid were observed. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hurler syndrome \t"
        },
        {
          "id": 2,
          "text": "Lesch-Nyhan disease"
        },
        {
          "id": 3,
          "text": "Hunter syndrome \t"
        },
        {
          "id": 4,
          "text": "Von Gierke syndrome "
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario with findings showing <strong>self-mutilation</strong> and laboratory values of <strong>hyperuricemia</strong> is most likely suggestive of <strong>Lesch-Nyhan disease</strong>.</p>\n<p id=\"viewer-foo\" class=\"xVISr Y9Dpf bCMSCT OZy-3 lnyWN yMZv8w bCMSCT public-DraftStyleDefault-block-depth0 fixed-tab-size public-DraftStyleDefault-text-ltr\"><span class=\"B2EFF public-DraftStyleDefault-ltr\">Lesch-Nyhan syndrome is an <strong>X-linked recessive</strong> disorder due to a <strong>complete deficiency</strong> of the <strong>hypoxanthine-guanine phosphoribosyltransferase</strong> (<strong>HGPRT</strong>). This deficiency results in an <strong>inability to salvage</strong> hypoxanthine or guanine leading to <strong>increased levels of phospho-ribosyl pyrophosphate (PRPP). </strong>Increased PRPP leads to increased purine synthesis, which is later degraded to <strong>uric acid</strong>. Increased hypoxanthine is also converted to uric acid.</span></p>\n<p id=\"viewer-243m5\" class=\"xVISr Y9Dpf bCMSCT OZy-3 lnyWN yMZv8w bCMSCT public-DraftStyleDefault-block-depth0 fixed-tab-size public-DraftStyleDefault-text-ltr\"><span class=\"B2EFF public-DraftStyleDefault-ltr\">The patients have <strong>intellectual disability</strong>, behaviors of <strong>self-injury</strong> like lip and finger biting, <strong>developmental delay</strong>, <strong>muscle dystonia,</strong> and extrapyramidal symptoms. </span></p>\n<p id=\"viewer-81sla\" class=\"xVISr Y9Dpf bCMSCT OZy-3 lnyWN yMZv8w bCMSCT public-DraftStyleDefault-block-depth0 fixed-tab-size public-DraftStyleDefault-text-ltr\"><span class=\"B2EFF public-DraftStyleDefault-ltr\">Diagnosis is made by the <strong>elevated</strong> levels of <strong>uric acid</strong> and by HGPRT enzyme assay.</span></p>\n<p class=\"xVISr Y9Dpf bCMSCT OZy-3 lnyWN yMZv8w bCMSCT public-DraftStyleDefault-block-depth0 fixed-tab-size public-DraftStyleDefault-text-ltr\"><span class=\"B2EFF public-DraftStyleDefault-ltr\">The image given below shows the metabolism of hypoxanthine and guanine by HGPRT.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d295845ea4924b19ab07ca33a23f65bex1280x1203.JPEG\" alt=\"Explanation Image\"><p><strong>Orange</strong> <strong>diaper syndrome</strong> can be an <strong>early indicator</strong> of <strong>Lesch-Nyhan syndrome</strong>. At birth, individuals with Lesch-Nyhan syndrome typically appear <strong>asymptomatic</strong>, with normal prenatal growth and development. The condition is often <strong>first detected </strong>through the presence of <strong>orange-coloured crystals</strong> in the <strong>diaper</strong>, resulting from <strong>hyperuricemia</strong>. Since hyperuricemia is a common feature across all variants of HGPRT deficiency, which causes Lesch-Nyhan syndrome, predicting associated neurodevelopmental abnormalities requires enzyme activity testing.</p><hr><h3>Related Pearl: Purine salvage deficiencies: Lesch-Nyhan syndrome and Adenosine deaminase deficiency(SCID)</h3><p><strong>Severe Combined Immunodeficiency(SCID):</strong></p>\n<p><strong>Adenosine deaminase</strong>&nbsp;enzyme deficiency is one of the major cause of SCID. It is also called as&nbsp;<strong>Glanzmann&ndash;Riniker syndrome.</strong></p>\n<p>SCID patients are usually affected by severe bacterial, viral, or fungal infections early in life and often present with interstitial lung disease, chronic diarrhea, and failure to thrive.</p>\n<p><strong>Lesch-Nyhan syndrome:</strong></p>\n<p>It is due to deficiency of the enzyme<strong> Hypoxanthine-guanine phosphoribosyltransferase(HGPRT). </strong>It is an X-linked recessive disease.</p>\n<p>Clinical features:</p>\n<ul>\n<li><span class=\"fontstyle0\">Intellectual disability</span></li>\n<li><span class=\"fontstyle0\">Self-mutilation</span></li>\n<li><span class=\"fontstyle0\">Aggression</span></li>\n<li>Hyperuricemia&nbsp;</li>\n<li><span class=\"fontstyle0\">Gout<br /></span></li>\n</ul>\n<p><span class=\"fontstyle0\">Treatment:</span></p>\n<ul>\n<li><span class=\"fontstyle0\">Allopurinol</span></li>\n<li><span class=\"fontstyle0\">Febuxostat</span></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6560",
      "difficulty": "easy"
    },
    {
      "text": "A neonate was brought with features of lethargy, and poor oral intake. On examination, a cataract was seen. Urine Benedict's test was positive but negative for Glucose. What will be the enzyme deficiency in this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Hexokinase \t"
        },
        {
          "id": 2,
          "text": "Galactokinase "
        },
        {
          "id": 3,
          "text": "Galactose-1-phosphate uridyl transferase"
        },
        {
          "id": 4,
          "text": "Phosphofructokinase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario of a neonate presenting with <strong>lethargy</strong>, and <strong>poor oral intake</strong>, with examination revealing a cataract and urine <strong>benedict's test</strong> was <strong>positive</strong> but <strong>negative</strong> for <strong>glucose,</strong> is suggestive of <strong>classical galactosemia </strong>and enzyme deficient is <strong>galactose-1-phosphate uridyl transferase.</strong></p>\n<p><strong>Galactose-1-phosphate uridyl transferase deficiency </strong>leads to <strong>classical galactosemia. </strong>It is an<strong> autosomal</strong> <strong>recessive</strong> disorder. Normally, newborns receive up to 40% of their intake as lactose (glucose + galactose). The deficiency of this enzyme leads to an inability to convert galactose-1-phosphate to uridine diphosphate galactose. This leads to the <strong>accumulation</strong> of <strong>galactose 1-phosphate</strong> and causes injury to the kidney, liver, and brain. </p>\n<p>Clinical features:</p>\n<ul>\n<li>Accumulation of galactose-1-phosphate in the liver causes liver damage &amp; leads to <strong>hepatomegaly</strong>, <strong>vomiting</strong>, and <strong>convulsions</strong>.</li>\n<li>Accumulation of galactose-1-phosphate depletes the liver of inorganic phosphate leading to <strong>diminished ATP</strong> synthesis which affects gluconeogenesis resulting in <strong>hypoglycemia</strong>.</li>\n<li>Accumulation of galactose-1-phosphate in the nerves causes<strong> intellectual disability</strong>.</li>\n<li>Accumulation of <strong>galactitol</strong> in the lens causes <strong>oil-drop cataracts.</strong></li>\n<li>Patients with galactosemia are at an increased risk of developing<strong><em> Escherichia coli</em> neonatal sepsis.</strong></li>\n</ul>\n<div class=\"page\" title=\"Page 202\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In uridyl transferase deficiency, the epimerase is present in adequate amounts, so that the galactosemic individual can still form UDPGal from glucose. This explains how normal growth and development of affected children can occur despite the galactose-free diets.</p>\n</div>\n</div>\n</div>\n</div>\n<p>Urinary reducing sugar <strong>(Benedict's test)</strong> and <strong>mucic acid test</strong> are positive. Direct enzyme assay using erythrocytes establishes the diagnosis.</p>\n<p><strong>Treatment</strong> is a <strong>galactose-free diet</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f245b4b2d54f41bf859920682ee1e3f3x1280x1142.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Hexokinase</strong> is a <strong>glycolytic enzyme</strong>, involved in maintaining intracellular glucose concentration by catalysing the<strong> first step</strong> in <strong>glucose metabolism</strong>, i.e., <strong>phosphorylation</strong> of <strong>intracellular glucose</strong>.  Its <strong>deficiency</strong> leads to <strong>hemolytic anaemia</strong>. <strong>Splenomegaly</strong> may be another presenting feature. </p>\n<p>Option B: <strong>Galactokinase</strong> is the enzyme responsible for the <strong>conversion</strong> of galactose to <strong>galactose 1-phosphate</strong>. <strong>Only cataract</strong> is seen in the deficiency of this enzyme because galactose-1-phosphate is not formed. Hence <strong>no toxic effects</strong> of this compound are manifested. </p>\n<p>Option D: <strong>Phosphofructokinase</strong> is a <strong>key regulatory enzyme</strong> of <strong>glycolysis</strong> and is necessary for the <strong>ATP-dependent</strong> conversion of <strong>fructose-6-phosphate</strong> to <strong>fructose-1,6-diphosphate</strong>. <strong>Tauri's disease</strong> is <strong>type VII glycogen storage disorder</strong> that results due to the <strong>deficiency</strong> of phosphofructokinase.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6562",
      "difficulty": "easy"
    },
    {
      "text": "A patient diagnosed with a rare homozygous recessive condition presented with ectopia lentis. In the peripheral smear, there was no megaloblastic anemia. Later, he was found to have elevated homocysteine levels in the blood. Which of the following supplementations will help the patient? ",
      "choices": [
        {
          "id": 1,
          "text": "Thiamine\t"
        },
        {
          "id": 2,
          "text": "Pyridoxine "
        },
        {
          "id": 3,
          "text": "Biotin\t"
        },
        {
          "id": 4,
          "text": "Riboflavin\t"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The vitamin that can be used as supplementation in this patient with <strong>homocystinuria</strong> is <strong>pyridoxine (vitamin B6)</strong>. </p>\n<p>Classical homocystinuria is an <strong>autosomal recessive</strong> disease <span>most commonly caused by a <strong>deficiency</strong> of the </span><strong>cystathionine β-synthase</strong>. The deficiency of this enzyme leads to an accumulation of homocysteine in the blood and a clinical syndrome of <strong>intellectual disability, </strong><strong>subluxated ocular lenses</strong>, <strong>long and slender extremities</strong>, arachnodactyly, and arterial and venous <strong>thrombi</strong>. The skeletal features of homocystinuria often mimic Marfan syndrome. Folic acid and vitamin B12 deficiency can also lead to homocystinuria with <strong>megaloblastic anemia</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8c708756ccdb447c80791b94f81660a2x1280x1045.PNG\" alt=\"Explanation Image\"><p>Demonstration of <strong>elevated total homocysteine</strong> in the blood confirms the diagnosis. 50% of the cases of homocystinuria are termed pyridoxine-responsive because large doses of pyridoxine can enhance the activity of deficient enzymes in these patients. Administration of large doses of pyridoxine (vitamin B6) restores the activity of the deficient enzyme in half of all cases of homocystinuria.</p>\n<p><strong>Folate supplementation</strong> is also added to overcome any folate deficiency that might occur due to increased conversion of homocysteine to methionine. For the other 50% of the patients, the treatment consists of <strong>methionine restriction</strong> and <strong>cysteine supplementation</strong>. In addition, betaine (methyl group donor), folate and vitamin B12 may be added.</p><hr><h3>Related Pearl: Homocystinuria</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c84307c25b08404ebad0ed6c97f95b35x1280x1169.JPEG\" alt=\"Pearl Image\"><p>The concept for treatment:</p>\n<ul>\n<li>Since homocysteine is produced from methionine, decreased dietary intake of methionine decreases the formation of homocysteine.</li>\n<li>As the end product of this cycle is cysteine, increased dietary intake of cysteine will decrease the conversion of methionine to homocysteine through negative feedback.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6540",
      "difficulty": "easy"
    },
    {
      "text": "You received a text message from your friend JOHN DOE about occupational exposure after he visited his doctor as shown below. What is the test used to diagnose? \n",
      "choices": [
        {
          "id": 1,
          "text": "Anthracosis \t"
        },
        {
          "id": 2,
          "text": "Lead poisoning \t"
        },
        {
          "id": 3,
          "text": "Silicosis \t"
        },
        {
          "id": 4,
          "text": "Asbestosis "
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The test for <strong>coproporphyrinogen</strong> levels is used as a <strong>screening test</strong> to diagnose <strong>lead poisoning</strong>.</p>\n<p><strong>Lead</strong> <strong>inhibits</strong> the enzymes <strong>delta-aminolevulinic acid (ALA) dehydratase</strong> and <strong>ferrochelatase</strong>, which are involved in <strong>heme synthesis</strong>. ALA is converted to <strong>porphobilinogen</strong> by <strong>ALA dehydratase</strong>, <strong>inhibited</strong> by <strong>lead</strong>. So, serum <strong>porphobilinogen levels</strong> are <strong>decreased</strong> in <strong>lead poisoning</strong>.</p>\n<p>Laboratory findings include the following:</p>\n<ul>\n<li>An <strong>elevated serum lead level</strong></li>\n<li>An <strong>elevated</strong> level of <strong>protoporphyrin</strong> in blood and <strong>elevated ALA</strong> and <strong>coproporphyrinogen</strong> in<strong> urine</strong></li>\n<li><strong>Microcytic anemia</strong> with <strong>basophilic stippling</strong> in peripheral smear due to ineffective heme synthesis</li>\n</ul>\n<p>Clinical features of <strong>chronic lead poisoning</strong> include <strong>facial pallor</strong>, anemia, basophilic stippling of red cells, <strong>blue lines</strong> in the <strong>gums</strong>, and retinal stippling. In the later phase, the findings are <strong>colic abdominal pain</strong>, constipation, nerve palsy, encephalopathy, and disturbance of the genito-urinary and cardiovascular systems.</p>\n<p>Diagnosis of lead poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Laboratory parameter</strong></td>\n<td><strong>Value</strong></td>\n<td><strong>Remarks</strong></td>\n</tr>\n<tr>\n<td>Coproporphyrin in urine</td>\n<td>&gt;150 mcg/L</td>\n<td><strong>Screening test</strong>- indicates exposure</td>\n</tr>\n<tr>\n<td>Aminolevulinic acid (ALA) in urine</td>\n<td>&gt;5 mg/L</td>\n<td>Indicates lead absorption</td>\n</tr>\n<tr>\n<td>Lead in blood</td>\n<td>&gt;70 mcg/dL</td>\n<td>Clinical symptoms appear</td>\n</tr>\n<tr>\n<td>Lead in urine</td>\n<td>0.8 mg/L</td>\n<td>Indicates lead absorption</td>\n</tr>\n<tr>\n<td>Basophilic stippling of RBCs</td>\n<td> </td>\n<td>Sensitive indicator</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p><hr><h3>Related Pearl: Lead Poisoning/Plumbism/Saturnism</h3><table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Lead Toxicity</strong></td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Occupational exposure</p>\n<p>Lead paint</p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Children - GI tract</p>\n<p>Adults - Respiratory tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<ul>\n<li>Binds to sulfhydryl groups and inhibits\n<ul>\n<li>ALA dehydratase</li>\n<li>Ferrochelatase</li>\n</ul>\n</li>\n<li>Inhibits pyrimidine 5' nucleotidase</li>\n<li>Competes with <strong>calcium</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(acute</strong> toxicity)</td>\n<td>\n<p>GI tract, Bone marrow, Peripheral nerves</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected <strong>(chronic</strong> toxicity)</td>\n<td>\n<p>CNS, Kidney</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Characteristic clinical findings</p>\n<p><strong>(ABCDEF)</strong></p>\n</td>\n<td>\n<p><strong>A - </strong>Anemia with basophilic stippling</p>\n<p><strong>B - </strong>Burtonian line (blue stippled line on gums)</p>\n<p><strong>C - </strong>Constipation and colic (abdominal pain)</p>\n<p><strong>D - </strong>Drop (wrist and foot drop) due to neuropathy</p>\n<p><strong>E - </strong>Encephalopathy- <strong>Mostly seen in infants</strong> presenting with severe ataxia, vomiting, lethargy, stupor, convulsions, and coma</p>\n<p><strong>F - Facial pallor (Earliest sign)</strong></p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood lead levels</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Calcium EDTA; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f40e712b5fc54f188419f68a701117fe.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6569",
      "difficulty": "easy"
    },
    {
      "text": "A 3-year-old child is brought to the OPD with complaints of persistent delayed developmental milestones, and hyperpigmented macular lesions on the body which are more pronounced on exposure to sunlight. What is the error in DNA multiplication?",
      "choices": [
        {
          "id": 1,
          "text": "Base excision repair\t"
        },
        {
          "id": 2,
          "text": "Nucleotide excision repair \t"
        },
        {
          "id": 3,
          "text": "DNA mismatch repair\t"
        },
        {
          "id": 4,
          "text": "Homologous recombination "
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The history points to a diagnosis of <strong>xeroderma pigmentosum</strong>. It is characterized by <strong>defective nucleotide excision repair</strong>.</p>\n<p>UV radiation leads to <strong>pyrimidine dimerization</strong> in DNA strands, preventing further replication by DNA polymerase. The nucleotide excision repair mechanism corrects the dimer formation in DNA. <strong>Xeroderma pigmentosum</strong> (XP) is an <strong>autosomal recessive</strong> genetic disorder characterized by an inability<span class=\"fontstyle0\"> to repair DNA pyrimidine dimers caused by UV exposure</span>. This leads to clinical and cellular hypersensitivity to ultraviolet (UV) radiation.</p>\n<p>In XP the skin is normal at birth and has a three-stage progression:</p>\n<ul>\n<li>Diffuse <strong>erythema,</strong> scaling, and <strong>freckle-like areas</strong> over the sun-exposed regions of the body at around 6 months of age.</li>\n<li>The second stage is characterized by <strong>poikiloderma</strong>. This results in <strong>skin atrophy, telangiectasias</strong> with mottled hyperpigmentation, and hyperpigmentation.</li>\n<li>In the <strong>third stage</strong> appearance of <strong>cutaneous malignancies</strong> like squamous cell carcinomas, malignant melanoma, basal cell carcinoma, and fibrosarcoma. </li>\n</ul>\n<p>Most of the cases with XP have ocular manifestations. Initially, it appears as <strong>photophobia</strong>, <strong>conjunctivitis</strong>, ectropion, and symblepharon with ulceration. Accumulation of pyrimidine dimer causes <strong>corneal opacification</strong> and <strong>neovascularization</strong>. Ocular malignancies are common in the lids, conjunctiva, and cornea as they are exposed to as much as facial skin. XP is ultimately fatal, and early detection of the skin lesions and their management with prevention of UV ray exposures prolong life.</p><hr><h3>Related Pearl: Human Diseases of DNA Damage Repair</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>DNA damage repair type</strong></p>\n</td>\n<td>\n<p><strong>Diseases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Nonhomologous End Joining Repair (NHEJ)</p>\n</td>\n<td>\n<p>Severe combined immunodeficiency disease (SCID)</p>\n<p>Radiation sensitive severe combined immunodeficiency disease(RS-SCID)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective Homologous Repair (HR)</p>\n</td>\n<td>\n<p>AT-like disorder (ATLD)</p>\n<p>Nijmegen breakage syndrome (NBS)</p>\n<p>Bloom syndrome (BS)</p>\n<p>Werner syndrome (WS)</p>\n<p>Rothmund-Thomson syndrome (RTS)</p>\n<p>Breast cancer suspectibility 1 and 2 (BRCA1, BRCA2)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Nucleotide Excision Repair (NER)</p>\n</td>\n<td>\n<p>Xeroderma pigmentosum (XP)</p>\n<p>Cockayne syndrome (CS)</p>\n<p>Trichothiodystrophy (TTD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Base Excision Repair (BER)</p>\n</td>\n<td>\n<p>MUTYH-associated polyposis (MAP)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Defective DNA Mismatch Repair (MMR)</p>\n</td>\n<td>\n<p>Hereditary nonpolyposis colorectal cancer (HNPCC)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6558",
      "difficulty": "easy"
    },
    {
      "text": "A patient with a family history of coronary heart disease presented with tendon xanthomas. His lipid profile showed serum LDL to be 280 mg/dL and triglyceride levels was 398 mg/dl. What is the likely defect in this patient?<div class='question-desc-html'><p>LDL - Low-density lipoprotein <br />VLDL - Very low-density lipoprotein </p></div>",
      "choices": [
        {
          "id": 1,
          "text": "LDL receptor defect  \t"
        },
        {
          "id": 2,
          "text": "LDL metabolism \t"
        },
        {
          "id": 3,
          "text": "VLDL metabolism \t"
        },
        {
          "id": 4,
          "text": "Lipoprotein lipase deficiency "
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical presentation with <strong>tendon xanthomas,</strong> <strong>elevated serum LDL</strong>  and <strong>elevated serum triglycerides</strong> points to a diagnosis of <strong>familial hypercholesterolemia </strong>and is due to a <strong>defect</strong> in <strong>LDL receptors</strong>.</p>\n<p>Familial hypercholesterolemia  <strong>(type IIa hyperlipoproteinemia)</strong> is an <strong>inherited disorder</strong> due to <strong>defects in LDL receptors</strong>. This defect causes a <strong>decrease</strong> in the <strong>uptake</strong> of<strong> LDL</strong> and <strong>cholesterol</strong>. As a result, the blood levels of both <strong>LDL</strong> and <strong>cholesterol </strong>are <strong>elevated</strong>. Such patients are at <strong>increased risk</strong> of developing <strong>atherosclerosis</strong> and <strong>coronary artery disease.</strong></p>\n<p>Features of FH: </p>\n<ul>\n<li>Painful polyarthritis and tendinitis are common.</li>\n<li>Physical findings seen are <strong>corneal arcus</strong> and <strong>tendon xanthomas</strong> over<strong> the Achilles tendon</strong> and the dorsum of the hands. Xanthomas are tumorous masses produced by foamy cell clusters (lipid-laden macrophages) found in the connective tissue of the skin and in tendons.</li>\n</ul>\n<p>Diagnosis is done clinically based on hypercholesterolemia with </p>\n<ul>\n<li aria-level=\"1\">LDL <strong>&gt; 190 mg/dl</strong>, </li>\n<li aria-level=\"1\">Family history of hypercholesterolemia and/or</li>\n<li aria-level=\"1\">Premature coronary artery disease.</li>\n</ul>\n<p>Treatment includes lifestyle changes, restriction of a fatty diet, and pharmacotherapy with <strong>statins</strong> in heterozygous FH patients.</p>\n<p>Recent drugs for specific treatment of homozygous FH are:</p>\n<ul>\n<li aria-level=\"1\"><strong>Lomitapide</strong>, a microsomal triglyceride transfer protein (MTP) inhibitor, and</li>\n<li aria-level=\"1\"><strong>Mipomersen</strong>, an antisense oligonucleotide against apoB.</li>\n</ul>\n<p>The image below shows Achilles tendon xanthoma and a plain lateral radiograph of both ankles showing bilateral symmetrical swellings (arrows) superior to the calcaneum respectively.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/864ecc007850432da511921ae29204c9x284x178.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3a4d2e15aa1c430891887f2f5685ec09x512x416.PNG\" alt=\"Explanation Image\"><p>Note: <strong>Lipoprotein lipase (LPL) deficiency</strong> causes type I hyperlipoproteinemia due to <strong>defects in LPL</strong> or <strong>apo C-II.</strong> <strong>Eruptive xanthomas</strong> are seen. <strong>Chylomicrons</strong> and <strong>VLDL</strong> are elevated. <strong>LDL</strong> and <strong>HDL</strong> are<strong> low.</strong> There is no risk for coronary disease.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6582",
      "difficulty": "medium"
    },
    {
      "text": "Which food item among these is the primary source of thiamine in Indians?\n",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Among the various food items given on the plate, the <strong>primary source</strong> of <strong>thiamine </strong>(<strong>vitamin B1</strong>) in the <strong>Indian diet </strong>is option <strong>4 i.e. chapati and rice</strong>.</p>\n<p>The thiamine content in various foods in decreasing order are as follows:</p>\n<ul>\n<li>Gingelly seeds</li>\n<li>Groundnut</li>\n<li>Bengal gram</li>\n<li><strong>Whole wheat</strong></li>\n<li><strong>Rice</strong></li>\n</ul>\n<p><strong>Gingelly (sesame) seeds </strong>have the <strong>highest </strong>content of <strong>thiamine</strong>.</p>\n<p>Thiamine is lost from rice during the process of milling. As it is a water-soluble vitamin, washing, and cooking rice cause further losses. Hence, it is advisable to <strong>avoid highly polished rice</strong> and <strong>eat parboiled</strong> or <strong>under-milled rice</strong>.</p>\n<p>Thiamine is essential for energy metabolism, particularly in carbohydrate processing. Its active form, <strong>thiamine diphosphate</strong>, acts as a <strong>coenzyme</strong> for three critical enzyme complexes: <strong>pyruvate dehydrogenase, α-ketoglutarate dehydrogenase,</strong> and <strong>branched-chain keto acid dehydrogenase.</strong> This coenzyme facilitates oxidative <strong>decarboxylation</strong> by forming a reactive carbanion that attaches to carbonyl groups like those in pyruvate, leading to the release of CO2. Thiamine diphosphate is also vital for <strong>transketolase</strong> in the <strong>pentose phosphate pathway</strong>.</p>\n<p><strong>Thiamine triphosphate</strong>, another form of thiamin, helps <strong>regulate nerve function</strong> by activating chloride channels in nerve membranes.</p>\n<p>A thiamine deficiency can cause several conditions such as <strong>beriberi,</strong> characterized by <strong>peripheral neuritis</strong>, which can also involve heart failure and edema. Additionally, thiamine deficiency can lead to <strong>Wernicke's encephalopathy </strong>and<strong> Korsakoff's psychosis</strong>, commonly associated with alcohol or drug abuse. The lack of thiamine impairs the conversion of pyruvate to acetyl-CoA, leading to increased levels of lactate and pyruvate in the blood, which can result in dangerous <strong>lactic acidosis</strong>, especially in those consuming high-carbohydrate diets.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f112b7a4bcab45a0b02404863a0eb91ax1280x1411.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/152832312f1d4fb6aa882be575991e79.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6567",
      "difficulty": "easy"
    },
    {
      "text": " A young female comes to the emergency department after ingesting 10 tablets of Phenobarbital. Which of the following components of the ETC is inhibited by this drug?",
      "choices": [
        {
          "id": 1,
          "text": "Succinate - Fe\t"
        },
        {
          "id": 2,
          "text": "Cytochrome I-II"
        },
        {
          "id": 3,
          "text": "Complex I to Q"
        },
        {
          "id": 4,
          "text": "Complex IV"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Phenobarbital</strong> is a barbiturate that<strong> inhibits complex I to Q </strong>of the <strong>electron transport chain</strong>. </p>\n<p><strong>Complex I</strong> of the electron transport chain is <strong>NADH-Q oxidoreductase</strong>. It <strong>oxidizes NADH</strong> and <strong>reduces coenzyme Q</strong>. <strong>Phenobarbital</strong> inhibits complex I to Q so that the <strong>electrons</strong> <strong>will not </strong>be able to be <strong>transferred</strong> from <strong>NADH to coenzyme Q</strong>, which is the first step in the electron transport chain. As a result, the rate of <strong>oxygen consumption</strong> will <strong>decrease</strong>.</p>\n<p>The electron transport chain (ETC) represents the <strong>final pathway</strong> through which electrons, originating from the oxidation of carbohydrates, fatty acids, and amino acids, are channeled toward a<strong> final reaction</strong> with <strong>oxygen</strong> to produce <strong>water</strong> and <strong>ATP</strong>. The ETC complexes are embedded in the <strong>inner mitochondrial membrane</strong>.</p>\n<p>The <strong>oxidation</strong> of compounds by ETC complexes leads to the release of <strong>free energy</strong>. This is used to <strong>pump H+ </strong>to the<strong> intermembrane space</strong>. This results in the formation of a <strong>proton motive force</strong> that is used for the <strong>phosphorylation</strong> of ADP to ATP. Thus, oxidation is coupled with phosphorylation to generate ATP. <strong>NADH</strong> generates <strong>2.5 ATP</strong> and <strong>FADH2</strong> generates <strong>1.5 ATP</strong>.</p>\n<p>The table below summarizes the inhibitors of the electron transport chain.  </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Complexes of ETC</strong></td>\n<td><strong>Inhibitors</strong></td>\n</tr>\n<tr>\n<td>\n<p>Complex I:</p>\n<p>NADH-Q oxidoreductase</p>\n</td>\n<td>Piericidin A, <strong>phenobarbital</strong>, rotenone</td>\n</tr>\n<tr>\n<td>\n<p>Complex II:</p>\n<p>Succinate-Q reductase</p>\n</td>\n<td>TTFA (thenoyltrifluoroacetone), carboxin, malonate</td>\n</tr>\n<tr>\n<td>\n<p>Complex III:</p>\n<p>Q- Cyt c oxidoreductase</p>\n</td>\n<td>BAL (British anti-lewisite), antimycin A</td>\n</tr>\n<tr>\n<td>\n<p>Complex IV:</p>\n<p>Cyt c oxidase</p>\n</td>\n<td>Hydrogen sulfide, carbon monoxide, cyanide </td>\n</tr>\n<tr>\n<td>\n<p>Complex V:</p>\n<p>ATP Synthase</p>\n</td>\n<td>Atractyloside, oligomycin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Electron transport chain: components and its inhibitors</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcc617cb8a8343ff8c0208d7726a0ba7x1280x1468.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c87ed88288804113994e57192a28d6f8x1280x969.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6552",
      "difficulty": "medium"
    },
    {
      "text": "A child presents to you with bone pain, hepatosplenomegaly, and pancytopenia. A trephine biopsy aspirate shows the following finding. Which of the following is the most likely enzyme deficient in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Galactocerebosidase"
        },
        {
          "id": 2,
          "text": "Glucocerebrosidase"
        },
        {
          "id": 3,
          "text": "Sphingomyelinase"
        },
        {
          "id": 4,
          "text": "Alpha 1,4-glucosidase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of a child with bone pain, hepatosplenomegaly, and trephine biopsy showing <strong>Gaucher's cell</strong> with a characteristic <strong>crumpled tissue paper</strong> appearance is suggestive of <strong>Gaucher's disease.</strong> The deficient enzyme is <strong>glucocerebrosidase</strong> (also known as <strong>beta-glucosidase</strong>).</p>\n<p>Gaucher's disease is an inborn error of metabolism caused due to a deficiency of <strong>beta-glucocerebrosidase</strong>. It is the most common <strong>lysosomal storage disorder</strong> and the mode of inheritance is <strong>autosomal recessive</strong>. There is an accumulation of lipid-laden macrophages in the spleen, liver, and other tissues.</p>\n<p>There are three clinical subtypes - type I (chronic non-neuronopathic), type II (acute neuronopathic), and type III (intermediate). Clinical features include anemia, thrombocytopenia, hepatosplenomegaly, and neurological features depending on the subtype. </p>\n<p><strong>Gaucher's cells</strong> are formed as a result of the accumulation of massive amounts of glucocerebrosides within the phagocytes. The cells have a fibrillary cytoplasm and give a <strong>crumpled tissue paper appearance</strong>.</p><hr><h3>Related Pearl: Examples of Sphingolipidoses (Lipids-Storage Disease)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eaf86bca861342ff84c303230efbb8bax1280x2017.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>S. No.</strong></p>\n</td>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme Deficiency</strong></p>\n</td>\n<td>\n<p><strong>Lipid </strong></p>\n<p><strong>Accumulating</strong></p>\n</td>\n<td>\n<p><strong>Clinical Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>1</p>\n</td>\n<td>\n<p>Tay–Sachs disease</p>\n</td>\n<td>\n<p>Hexosaminidase A</p>\n</td>\n<td>\n<p>Ganglioside</p>\n</td>\n<td>\n<p>Mental retardation, blindness, muscular weakness</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>2</p>\n</td>\n<td>\n<p>Sandhoff's disease</p>\n</td>\n<td>\n<p>Hexosaminidase A and B</p>\n</td>\n<td>\n<p>Globoside &amp; Ganglioside</p>\n</td>\n<td>\n<p>Similar to Tay–Sachs disease but also has hepatosplenomegaly and skeletal dysplasias</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>3</p>\n</td>\n<td>\n<p>Fabry's disease</p>\n</td>\n<td>\n<p>α-Galactosidase</p>\n</td>\n<td>\n<p>Globotriaosyl-ceramide</p>\n</td>\n<td>\n<p>Skin rash, kidney failure (full symptoms only in males; X-linked recessive)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>4</p>\n</td>\n<td>\n<p>Metachromatic leukodystrophy</p>\n</td>\n<td>\n<p>Arylsulfatase A</p>\n</td>\n<td>\n<p>3-Sulfogalactosyl-ceramide</p>\n</td>\n<td>\n<p>Mental retardation and psychologic disturbances in adults; demyelination</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>5</p>\n</td>\n<td>\n<p>Krabbe disease</p>\n</td>\n<td>\n<p>β-Galactosidase</p>\n</td>\n<td>\n<p>Galactosylceramide</p>\n</td>\n<td>\n<p>Mental retardation; myelin almost absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>6</p>\n</td>\n<td>\n<p>Gaucher's disease</p>\n</td>\n<td>\n<p>β-Glucosidase</p>\n</td>\n<td>\n<p>Glucosylceramide</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, erosion of long bones, mental retardation in infants</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>7</p>\n</td>\n<td>\n<p>Niemann–Pick disease</p>\n</td>\n<td>\n<p>Sphingomyelinase</p>\n</td>\n<td>\n<p>Sphingomyelin</p>\n</td>\n<td>\n<p>Enlarged liver and spleen, mental retardation; fatal in early life</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>8</p>\n</td>\n<td>\n<p>Farber's disease</p>\n</td>\n<td>\n<p>Ceramidase</p>\n</td>\n<td>\n<p>Ceramide</p>\n</td>\n<td>\n<p>Hoarseness, dermatitis, skeletal deformation, mental retardation; fatal in early life</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9c593526d9794bf0a6c44ed277bb451e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6559",
      "difficulty": "easy"
    },
    {
      "text": "A 32-year-old lady comes with complaints of erythematous scaly rash, loose stools, and cognitive dysfunction. The rash involved her forearm, neck, and face. She seems to have difficulty remembering things from the recent past. Her electrolytes are within normal range. She admits to having shifted to a corn-based diet due to economic reasons. Which of the following would improve her symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Oral Nicotinamide supplementation"
        },
        {
          "id": 2,
          "text": "High dose of IV thiamine"
        },
        {
          "id": 3,
          "text": "High Dose Vitamin C"
        },
        {
          "id": 4,
          "text": "Stop corn diet"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical features suggests the diagnosis of <strong>pellagra,</strong> due to her <strong>corn-based diet</strong>. <strong>Oral nicotinamide </strong>supplements can improve her symtpoms. </p>\n<p><strong>Niacin</strong> can be synthesized in the body from <strong>tryptophan.</strong> Two compounds, <strong>nicotinic acid</strong> and <strong>nicotinamide,</strong> have the biological activity of <strong>niacin.</strong> The <strong>nicotinamide</strong> ring of the coenzymes <strong>nicotinamide adenine dinucleotide</strong> (NAD) and <strong>nicotinamide adenine dinucleotide phosphate</strong> (NADP) participate in <strong>oxidation/reduction</strong> reactions.</p>\n<p>The initial symptoms of pellagra include <strong>loss</strong> of <strong>appetite, generalized weakness, irritability, abdominal pain,</strong> and <strong>vomiting.</strong> This is followed by bright <strong>red glossitis</strong> and a characteristic <strong>pigmented, scaly skin rash</strong> in <strong>sun-exposed</strong> areas. This rash is known as <strong>Casal’s</strong> <strong>necklace</strong> when it forms a ring around the neck. </p>\n<p>The 4Ds of pellagra:</p>\n<ul>\n<li>Diarrhea</li>\n<li>Dermatitis</li>\n<li>Dementia, leading to</li>\n<li>Death</li>\n</ul>\n<p>It is diagnosed by measuring urinary levels of <strong>2-methyl nicotinamide</strong> and <strong>2-pyridone.</strong></p>\n<p>Other options: </p>\n<p>Option B: Thiamine (Vitamin B1) deficiency leads to conditions like <strong>beriberi</strong> and <strong>Wernicke-Korsakoff</strong> syndrome, which are characterized by symptoms such as <strong>muscle weakness, peripheral</strong> neuropathy, cardiovascular issues, and confusion. While <strong>cognitive dysfunction</strong> can result from <strong>thiamine deficiency, rash</strong> and <strong>loose stools</strong> do not fit with <strong>thiamine deficiency.</strong> Therefore, thiamine would not address the full spectrum of this patient’s symptoms.</p>\n<p>Option C: <strong>Vitamin</strong> <strong>C deficiency</strong> causes <strong>scurvy,</strong> which is associated with symptoms like <strong>bleeding gums, bruising, joint pain,</strong> and fatigue. Scurvy is not associated with a <strong>rash</strong> like the one described, nor does it typically cause <strong>cognitive dysfunction</strong> or <strong>diarrhea.</strong> Hence, high-dose vitamin C would not improve this patient’s symptoms.</p>\n<p>Option D: <strong>Corn-based diets</strong> are <strong>low</strong> in <strong>niacin</strong> and <strong>tryptophan,</strong> leading to <strong>pellagra</strong> over time, especially if the diet is <strong>not balanced</strong> with other niacin-rich foods. While <strong>stopping</strong> the <strong>corn-based</strong> diet could prevent further <strong>niacin deficiency,</strong> it will not <strong>immediately address</strong> the <strong>existing deficiency</strong> and symptoms like rash, diarrhea, and cognitive dysfunction. The patient would still need <strong>niacin supplementation</strong> to resolve the current symptoms.</p><hr><h3>Related Pearl: Vitamin Deficiency States (Water-soluble Vitamins)</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Vitamin</strong></p>\n</td>\n<td>\n<p><strong>Deficiency State</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Thiamine (<strong>B<sub>1</sub></strong>)</p>\n</td>\n<td>\n<p><strong>Beriberi</strong></p>\n<p>Wernicke&ndash;Korsakoff&rsquo;s syndrome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Riboflavin (<strong>B<span>2</span></strong>)</p>\n</td>\n<td>\n<p>Cheilosis, Magenta-coloured tongue,&nbsp;</p>\n<p>Glossitis, Seborrheic dermatitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Niacin (<strong>B<span>3</span></strong>)</p>\n</td>\n<td>\n<p><strong>Pellagra</strong></p>\n<p>Dermatitis, Diarrhea, Dementia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pantothenic acid (<strong>B<span>5</span></strong>)</p>\n</td>\n<td>\n<p><strong>Burning foot syndrome</strong> (historically called as \"Nutritional melalgia\")</p>\n<div class=\"page\" title=\"Page 90\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Dermatitis, enteritis, alopecia, ataxia</p>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pyridoxine (<strong>B<span>6</span></strong>)</p>\n</td>\n<td>\n<p>Microcytic anemia, convulsions, depression</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Biotin (<strong>B<span>7</span></strong>)</p>\n</td>\n<td>\n<p>Relatively unknown</p>\n<p>Dermatitis, atrophic glossitis, alopecia, paraesthesia, muscle pain, anorexia, hallucinations</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Folic acid (<strong>B<span>9</span></strong>)</p>\n</td>\n<td>\n<p>Megaloblastic anemia, neuropathy, neural tube defects, atrophic glossitis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cobalamin (<strong>B<span>12</span></strong>)</p>\n</td>\n<td>\n<p>Pernicious anemia, dementia, spinal cord degeneration, homocysteinemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Ascorbic acid (<strong>C</strong>)</p>\n</td>\n<td>\n<p><strong>Scurvy</strong></p>\n<p>Ecchymosis, bleeding gums, poor wound healing, fatigue, joint effusion, Scorbutic rosary</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Conditions Associated with Pellagra-like Symptoms</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Condition/Disease</strong></p>\n</td>\n<td>\n<p><strong>Reason for niacin deficiency</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hartnup disease</p>\n</td>\n<td>\n<p>Intestinal &amp; renal malabsorption of tryptophan</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carcinoid syndrome</p>\n</td>\n<td>\n<p>Overproduction of serotonin that causes diversion of  tryptophan from NAD+ Pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitamin B6 deficiency</p>\n</td>\n<td>\n<p>Defective kynureninase pathway</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maize rich diet</p>\n</td>\n<td>\n<p>Niacin is in unavailable niacytin form</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Jowar diet (Sorghum)</p>\n</td>\n<td>\n<p>Increase leucine content inhibit QPRTase enzyme</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7131",
      "difficulty": "medium"
    },
    {
      "text": "A 3-month-old child was brought to the clinic with a history of difficulty in feeding and failure to thrive. On examination,  the child is floppy, 48 cm in length and weighs 2.8 kg. There is generalized hypotonia, macroglossia and hepatomegaly. The chest x-ray of the child is given below. What is the most likely diagnosis?\n",
      "choices": [
        {
          "id": 1,
          "text": "Ebstein's anomaly"
        },
        {
          "id": 2,
          "text": "Pompe's disease"
        },
        {
          "id": 3,
          "text": "Transposition of great arteries"
        },
        {
          "id": 4,
          "text": "Von- Gierke's disease"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The child with a clinical history of <strong>difficulty feeding</strong> and <strong>failure to thrive</strong> with <strong>generalised hypotonia</strong>, macroglossia, <strong>hepatomegaly</strong> and chest x-ray findings of <strong>massive cardiomegaly</strong> suggest a diagnosis of <strong>Pompe's disease</strong>.</p>\n<p>Pompe's disease is a <strong>glycogen storage disorder(type II) </strong>caused by a deficiency of <strong>lysosomal acid maltase</strong> (alpha-glucosidase) which leads to the accumulation of<strong> glycogen</strong> in the lysosomes of the <strong>liver</strong> (hepatomegaly), <strong>skeletal muscles</strong> in the form of large vacuoles (hypotonia and weakness), <strong>cardiac muscles </strong>(<strong>hypertrophic cardiomyopathy</strong>). The child generally dies by the age of 2 years due to cardiac failure. The <strong>adult form</strong> presents with <strong>muscle dystrophies</strong>.</p>\n<p>Laboratory findings show <strong>elevated</strong> levels of serum <strong>creatine kinase</strong> (CK), <strong>aspartate transaminase</strong> (AST), <strong>alanine transaminase</strong> (ALT), and <strong>lactate dehydrogenase</strong> (LDH). Urine <strong>glucose tetrasaccharide</strong>, a glycogen breakdown metabolite, is a reliable biomarker for disease severity and treatment response. Treatment includes enzyme replacement therapy with recombinant enzyme <strong>a-glucosidase alfa</strong> (Myozyme).</p>\n<p>Given below is the image of muscle biopsy showing glycogen-positive vacuoles.</p><img src=\"https://cdn1.dailyrounds.org/uploads/7b09badb0f8f4f48893903bd9ba1d070.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A- <strong>Ebstein's anomaly </strong>is the teratogenic effect of maternal <strong>lithium </strong>consumption which causes a <strong>cyanotic heart disease</strong> in the newborn with <strong>atrialization of the right ventricle </strong>and<strong> conduction defects</strong>. The chest X-ray will show a <strong>box-shaped enlargement </strong>of the right atrium and <strong>pulmonary oligemia</strong>.</p>\n<p>Option C- <strong>Transposition of great vessels </strong>is <strong>cyanotic congenital heart disease</strong> where there is a switch in the position of two main arteries i.e. <strong>pulmonary artery</strong> and <strong>aorta</strong>. X-ray shows of <strong>egg-on-string</strong> appearance with <strong>pulmonary plethora.</strong></p>\n<p>Option D- <strong>Von Gierke disease</strong> occurs due to a deficiency of <strong>glucose-6-phosphatase</strong>. Patients present commonly in 3-4 months of age with hypoglycemia, lactic acidosis, hepatomegaly, growth retardation, hyperuricemia, and hyperlipidemia.</p><hr><h3>Related Pearl: Glycogen Storage Diseases</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/782e85c36f0648698a222dca988adfabx1280x1863.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Enzyme deficiency</strong></p>\n</td>\n<td>\n<p><strong>Symptoms</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type 0</p>\n</td>\n<td>\n<p>Glycogen synthase</p>\n</td>\n<td>\n<p>Hypoglycemia</p>\n<p>Early death</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ia</p>\n<p><strong>Von Gierke's disease</strong></p>\n</td>\n<td>\n<p>Glucose-6- phosphatase</p>\n</td>\n<td>\n<p>Hepatomegaly and renomegaly&nbsp;due to glycogen accumulation</p>\n<p>Severe fasting hypoglycemia</p>\n<p>Growth failure</p>\n<p>Lactic acidosis</p>\n<p>Hyperuricemia</p>\n<p>Hyperlipidemia</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type Ib</p>\n</td>\n<td>\n<p>Endoplasmic reticulum glucose-6- phosphate transporter</p>\n</td>\n<td>\n<p>Same as Von Gierke's disease</p>\n<p>Recurrent infections due to impaired neutrophil function</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type II</p>\n<p><strong>Pompe's disease</strong></p>\n</td>\n<td>\n<p>Lysosomal &alpha;1,4:1,6 glucosidase</p>\n<p>(Acid maltase)</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Death by age ~ 2 years (infantile variant)</p>\n<p>Cardiomegaly and heart failure</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type III</p>\n<p><strong>Cori's/Forbes disease</strong></p>\n<p>(Limit dextrinosis)</p>\n</td>\n<td>\n<p>Glycogen debranching enzyme</p>\n</td>\n<td>\n<p>Muscle weakness</p>\n<p>Fasting hypoglycemia</p>\n<p>Hepatomegaly due to accumulation of branched-chain polysaccharide (limit dextrins)</p>\n<p>Growth retardation</p>\n<p>Normal lactate and uric acid levels</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type IV</p>\n<p><strong>Andersen disease</strong></p>\n</td>\n<td>\n<p>Glycogen branching enzyme</p>\n</td>\n<td>\n<p>Failure to thrive</p>\n<p>Hepatomegaly due to accumulation of polysaccharides with few branch points</p>\n<p>Death at age ~ 5 years</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type V</p>\n<p><strong>McArdle disease</strong></p>\n</td>\n<td>\n<p>Muscle glycogen phosphorylase</p>\n</td>\n<td>\n<p>Exercise-induced cramps</p>\n<p>Renal failure due to rhabdomyolysis and myoglobinuria</p>\n<p>Second wind phenomenon</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VI</p>\n<p><strong>Her's disease</strong></p>\n</td>\n<td>\n<p>Liver glycogen phosphorylase</p>\n</td>\n<td>\n<p>Generally benign</p>\n<p>Mild hypoglycemia</p>\n<p>Hepatomegaly</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GSD type VII</p>\n<p><strong>Tarui's disease</strong></p>\n</td>\n<td>\n<p>Muscle phosphofructokinase</p>\n</td>\n<td>\n<p>Exercise-induced muscle cramps and weakness</p>\n<p>Growth retardation</p>\n<p>Hemolytic anemia</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Radiological findings in some congenital heart defects</h3><p><strong>Boot shaped heart - Tetralogy of Fallot (TOF)</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b8d455f894f24e8e9c147e7c3a178428x510x558.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Egg on string appearance - Transposition of Great Arteries (TGA)</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad3fe6b6422548c8856299317c3e47c5x510x522.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Snowman's heart appearance or figure of 8 appearance</strong> -&nbsp;<strong>Supracardiac TAPVC</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c4d273d1af7445fdad02e659555c9e69x510x494.GIF\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Box Shaped Heart - Ebstein's Anomaly</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d07d5041004645849e8cce1dd37bd092x510x640.GIF\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/0cbea93263984d668074e77eb4e5c40e.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7037",
      "difficulty": "medium"
    },
    {
      "text": "A patient presented with multiple yellowish raised plaques on eyelids, xanthomas on the achilles tendon. What is the likely cause for the patient's presentation?",
      "choices": [
        {
          "id": 1,
          "text": "Familial hypercholesterolemia"
        },
        {
          "id": 2,
          "text": "Tangier's disease"
        },
        {
          "id": 3,
          "text": "Xanthomatosis"
        },
        {
          "id": 4,
          "text": "Fabry's disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical presentation with yellowish, raised <strong>plaques on eyelids</strong>, and <strong>tendon xanthomas</strong> points to a diagnosis of <strong>familial hypercholesterolemia (FH).</strong></p>\n<p>Familial hypercholesterolemia (type IIa hyperlipoproteinemia) is an <strong>inherited disorder</strong> due to defects in<strong> LDL receptors</strong> and<strong> Apo B100</strong>. This decreases the uptake of <strong>Low-density lipoprotein</strong> and <strong>cholesterol</strong> leading to their increased levels in the blood. The increased LDL accumulates in the blood vessels causing <strong>atherosclerosis </strong>(premature coronary artery disease)and in the Achilles tendon causing <strong>tendon xanthomas</strong>. Xanthomas are tumorous masses produced by foamy cell clusters (lipid-laden macrophages) found in the connective tissue of the skin and tendons. Patients can also have yellowish plaques around the eyes (<strong>Xanthelasma</strong>) and <strong>corneal arcus</strong>.</p>\n<p>Treatment includes lifestyle changes, restriction of a fatty diet, and pharmacotherapy with <strong>statins</strong> in heterozygous FH patients.</p>\n<p>The images below show Achilles tendon xanthoma and xanthelasma respectively:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/864ecc007850432da511921ae29204c9x284x178.PNG\" alt=\"Explanation Image\"><img src=\"https://cdn1.dailyrounds.org/uploads/7dbbfa81557f4459849ff45d5b267b06.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B: <strong>Tangier’s disease</strong> is a <strong>hypolipoproteinemia </strong>caused by a mutation of the <strong>ABCA1 gene</strong>. Enlarged <strong>orange tonsils</strong> are pathognomonic. <strong>Low HDL</strong> levels are seen. There is an increased risk for atherosclerosis.</p>\n<p>The image below shows enlarged yellow-orange coloured tonsils in Tangier's disease.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/dd350316b6c9423d8b3a4b0547759642x225x225.JPEG\" alt=\"Explanation Image\"><p>Option C: <strong>Xanthomatosis</strong> is the <strong>deposition of lipids </strong>in various parts of the body like tendon xanthomas, xanthelasma, eruptive and tuberous xanthomas. This is a <strong>sign</strong> of underlying <strong>lipid metabolism disorders</strong>.</p>\n<p>Option D: <strong>Fabry's disease</strong> is a<strong> lysosomal storage disorder </strong>with a defect in <strong>alpha-galactosidase</strong>. It causes angiokeratomas, hypohidrosis and characteristic Maltese cross deposits in urine.</p><hr><h3>Related Pearl: Familial Dyslipidemias</h3><table>\n<tbody>\n<tr>\n<td>Type</td>\n<td>Increased levels&nbsp;</td>\n<td>Manifestation</td>\n</tr>\n<tr>\n<td>1. Hyperchylomicronemia(type I hyperlipoproteinemia)</td>\n<td>Chylomicrons, VLDL, TG&nbsp;</td>\n<td>Pancreatitis, hepatosplenomegaly, and xanthomas</td>\n</tr>\n<tr>\n<td>2.&nbsp;Familial hypercholesterolemia(type II&nbsp;hyperlipoproteinemia)</td>\n<td>LDL and cholesterol</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>3. Dysbetalipoproteinemia(type III hyperlipoproteinemia)</td>\n<td>Chylomicrons and VLDL</td>\n<td>Atherosclerosis and xanthomas</td>\n</tr>\n<tr>\n<td>4. Hypertriglyceridemia(type IV hyperlipoproteinemia)</td>\n<td>VLDL and TG</td>\n<td>Pancreatitis</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7032",
      "difficulty": "easy"
    },
    {
      "text": "A child presented to the OPD with complaints of fatigue and muscle weakness while exercising. Laboratory investigations found that LCFA oxidation was affected. A muscle biopsy was done which revealed the presence of fat vacuoles. What is the probable diagnosis?<div class='question-desc-html'><p>LCFA- Long-chain fatty acid</p>\n<p>LPL- Lipoprotein lipase</p>\n<p>LDL- Low-density lipoprotein</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "LDL defect"
        },
        {
          "id": 2,
          "text": "LPL defect"
        },
        {
          "id": 3,
          "text": "Fatty acid synthase defect"
        },
        {
          "id": 4,
          "text": "Carnitine deficiency"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario of a child with <strong>fatigue</strong> and <strong>muscle weakness</strong> on exercise with laboratory findings of <strong>LCFA oxidation deficiency</strong> and <strong>fat vacuoles </strong>on <strong>muscle biopsy</strong> suggests a diagnosis of <strong>carnitine deficiency</strong>.</p>\n<p>Carnitine deficiency is a defect in fatty acid oxidation that leads to <strong>hypoketotic</strong> <strong>hypoglycemia </strong>and <strong>hyperammonemia</strong>. Carnitine transports <strong>activated LCFA </strong>(long chain fatty acyl CoA) from the cytoplasm to the <strong>mitochondria </strong>for<strong> beta-oxidation</strong> (as they cannot cross the mitochondrial membrane), carnitine deficiency impairs this transport causing <strong>accumulation</strong> of<strong> lipids</strong> (skeletal muscle weakness). This excess fatty acid <strong>inhibits </strong>the<strong> urea cycle</strong> causing hyperammonemia. Since beta-oxidation cannot occur, <strong>energy production </strong>is<strong> reduced</strong>, and there is hypoglycemia without a corresponding increase in ketone bodies (hypoketotic) during times of glucose depletion such as exercise.</p>\n<p>The role of carnitine in the metabolism of fatty acids is demonstrated in the image below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/29bd1a96f29a402d93683973dfc54bcfx1280x1913.JPEG\" alt=\"Explanation Image\"><p>Clinical features of carnitine deficiency begin in childhood and include poor feeding, lethargy, liver dysfunction and hepatomegaly, hypotonia, and dilated cardiomyopathy. <strong>Treatment</strong> involves <strong>oral supplementation of carnitine</strong>.</p>\n<p>Other options:</p>\n<p>Option A: An <strong>increase </strong>in <strong>LDL</strong> can cause <strong>hyperlipoproteinemia</strong>, and reduced LDL can cause defective absorption of fat-soluble vitamins.</p>\n<p>Option B: <strong>LPL</strong> is involved in hydrolysis of lipoproteins in the blood to free fatty acid and glycerol which are then taken up by the tissues. A defective LPL can cause <strong>type 1 familial chylomicronemia syndrome</strong> presenting as<strong> </strong>pancreatitis.</p>\n<p>Option C: <strong>Fatty acid synthase</strong> is a <strong>multienzyme complex</strong> involved in <strong>fatty acid synthesis</strong> in the cytosol which when defective may impair energy production, essential fatty acids, and affect metabolic pathways. There is no accumulation of fat vacuoles since fatty acids are not synthesised.</p><hr><h3>Related Pearl: Enzymes Involved in Fatty acid Transfer Across Mitochondrial membrane</h3><table>\n<tbody>\n<tr>\n<td>\n<p>Enzyme</p>\n</td>\n<td>\n<p>Site of action</p>\n</td>\n<td>\n<p>Action</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Acyl-CoA synthetase (Thiokinase)</p>\n</td>\n<td>\n<p>Outer mitochondrial membrane</p>\n</td>\n<td>\n<p>Converts free fatty acid into Acyl CoA</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carnitine palmitoyl transferase-I</p>\n</td>\n<td>\n<p>Outer mitochondrial membrane</p>\n</td>\n<td>\n<p>Transfers long-chain acyl group from CoA to carnitine, forming acylcarnitine.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carnitine-acylcarnitine translocase</p>\n</td>\n<td>\n<p>Inner  mitochondrial membrane</p>\n</td>\n<td>\n<p>Help Acylcarnitine to penetrate the inner membrane</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Carnitine palmitoyl transferase-II</p>\n</td>\n<td>\n<p>Inner  mitochondrial membrane</p>\n</td>\n<td>\n<p>Along with carnitine palmitoyl transferase I oxidizes long-chain fatty acids in the mitochondria. </p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7d27598800f5469bade0f988478cd9f3x1280x1913.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Beta-oxidation of Fatty Acids</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e5378985a79641669d91f9ecd81a4d9bx907x799.PNG\" alt=\"Pearl Image\"><p>Note:&nbsp;<strong>Carnitine palmitoyltransferase I</strong>&nbsp;(<strong>CPT1</strong>) is also known as&nbsp;<strong>carnitine acyltransferase I</strong>,</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7021",
      "difficulty": "medium"
    },
    {
      "text": " A mother came back home to see her child suffering from difficulty breathing. The child had contact with rotenone while trying to bathe their pet. The child was taken to the emergency department and she later passed away. Inhibition of which of the following enzymes was the likely cause of her death?",
      "choices": [
        {
          "id": 1,
          "text": "Cytochrome c reductase"
        },
        {
          "id": 2,
          "text": "Succinate dehydrogenase"
        },
        {
          "id": 3,
          "text": "NADH-Q oxidoreductase"
        },
        {
          "id": 4,
          "text": "Cytochrome oxidase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical vignette, inhibition of<strong> NADH-Q oxidoreductase </strong>by<strong> rotenone </strong>was the likely cause of breathlessness, followed by death in this child.</p>\n<p>Rotenone inhibits <strong>complex I</strong>, thereby inhibiting the <strong>respiratory chain,</strong> so electrons cannot be transferred to oxygen. This <strong>halts ATP production</strong>,<strong> </strong>leading to an energy deficit in the cells, eventually causing cell death. The ETC constitutes four enzyme complexes:</p>\n<ul>\n<li><strong>Complex I: NADH-Q oxidoreductase</strong></li>\n<li>Complex II: Succinate-Q reductase</li>\n<li>Complex III: Q-cytochrome c oxidoreductase</li>\n<li>Complex IV: cytochrome c oxidase</li>\n</ul>\n<p>Components of complex I are <strong>FMN</strong> and <strong>Fe-S complex</strong>. NADH-Q oxidoreductase catalyses the transfer of electrons from NADH to coenzyme Q, along with the transfer of four H+ across the membrane.</p><hr><h3>Related Pearl: Electron transport chain: components and its inhibitors</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bcc617cb8a8343ff8c0208d7726a0ba7x1280x1468.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c87ed88288804113994e57192a28d6f8x1280x969.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7018",
      "difficulty": "easy"
    },
    {
      "text": "A child suffering from phenylketonuria was started on necessary dietary modifications but the neurological symptoms persisted. Phenylalanine hydroxylase levels in the serum are normal. Which of the following enzymes is likely to be deficient in this case? ",
      "choices": [
        {
          "id": 1,
          "text": "Tyrosine hydroxylase"
        },
        {
          "id": 2,
          "text": "Homogentisate oxidase"
        },
        {
          "id": 3,
          "text": "Tetrahydrobiopterin synthase"
        },
        {
          "id": 4,
          "text": "Dopa decarboxylase"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This child with <strong>phenylketonuria </strong>with <strong>neurological symptoms</strong> not improving despite dietary modifications and<strong> normal serum phenylalanine hydroxylase </strong>level is suggestive of <strong>tetrahydrobiopterin (BH4) synthase deficiency.</strong></p>\n<p>A diet low in phenylalanine (eg: tapioca) is the mainstay of treatment for classic phenylketonuria but may not be sufficient in BH4 deficiency where <strong>supplementation </strong>with<strong> BH4 </strong>and<strong> </strong>deficient<strong> neurotransmitter precursors (L-dopa)</strong> is required to overcome the block.</p>\n<p><strong>Phenylketonuria </strong>(PKU) is an inborn error of metabolism seen due to a defect in the enzyme <strong>phenylalanine hydroxylase </strong>(classic phenylketonuria) and less commonly, due to a defect in <strong>BH4 synthase </strong>(non-classical). These defects result in the impaired conversion of <strong>phenylalanine </strong>to<strong> tyrosine.</strong> The patient develops clinical features due to elevated levels of<strong> </strong>phenylalanine metabolites and decreased levels of tyrosine. The excess phenylalanine in the blood is metabolized to <strong>phenylpyruvate (positive ferric chloride)</strong> and <strong>phenylacetate (mousy odour) </strong>which are excreted in the urine. Infants appear normal at birth and gradually develop symptoms of <strong>hyperreflexia</strong>,<strong> seizures</strong>,<strong> hypopigmentation</strong>,<strong> low IQ</strong>,<strong> hyperactivity</strong>, and <strong>tremors.</strong></p>\n<p><strong>Tandem mass spectroscopy</strong> is the investigation of choice. <strong>Guthrie test </strong>is a screening test that shows with absence of growth of <em>Bacillus subtilis</em>. The<strong> ferric chloride</strong> test is positive with the development of a transient blue-green colour.</p>\n<p>Other options - </p>\n<p>Option A: <strong>Tyrosine hydroxylase</strong> is the <strong>rate-limiting enzyme </strong>in the synthesis of epinephrine,<strong> </strong>converts<strong> tyrosine </strong>to <strong>DOPA, </strong>its deficiency does not cause phenylketonuria </p>\n<p>Option B:  <strong>Homogentisic acid oxidase </strong>converts <strong>homogentisic acid </strong>to<strong> maleylacetoacetic acid</strong> in the tyrosine degradation pathway and its deficiency causes <strong>alkaptonuria</strong> with a dark colour of urine on standing, bluish-black pigmentation in connective tissue (ochronosis) and arthritis.</p>\n<p>Option D: <strong>Dopa decarboxylase</strong> is another enzyme involved in the synthesis of epinephrine. It converts <strong>DOPA </strong>to<strong> dopamine</strong> in the presence of <strong>vitamin B6</strong>. While enzymes involved in epinephrine synthesis cause neurological dysfunction, they do not cause phenylketonuria as such.</p><hr><h3>Related Pearl: Phenylketonuria</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1a79bc9a0618454db8f2bfa6916ae3bbx1280x1001.JPEG\" alt=\"Pearl Image\"><ol>\n<li>BH<sub>4</sub> - tetrahydrobiopterin (or sapropterin, a synthetic form of BH<sub>4</sub>)</li>\n</ol><hr><h3>Related Pearl: Amino acid Enzymatic Disorders and the Associated Enzymes</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Enzyme defect</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Phenylketonuria</p>\n</td>\n<td>\n<p>Phenylalanine hydroxylase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinosis (Tyrosinemia type I)</p>\n</td>\n<td>\n<p>Maleyl Acetate isomerase or Fumarylacetoacetate hydrolase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Maple syrup urine disease&nbsp;</p>\n</td>\n<td>\n<p>Branched-chain alpha-keto acid dehydrogenase(BCKAD)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Alkaptonuria</p>\n</td>\n<td>\n<p>Homogentisate oxidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Albinism</p>\n</td>\n<td>\n<p>Tyrosinase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type I</p>\n</td>\n<td>\n<p>Cystathionine synthase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Homocystinuria type II</p>\n</td>\n<td>\n<p>Defect in methylcobalamin formation</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cystathioninuria</p>\n</td>\n<td>\n<p>Cystathionase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tyrosinemia type II or Richner-Hanhart syndrome</p>\n</td>\n<td>\n<p>Tyrosine transaminase or Tyrosine aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Primary hyperoxaluria</p>\n</td>\n<td>\n<p>Alanine glyoxalate aminotransferase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypervalinemia</p>\n</td>\n<td>\n<p>Valine transaminase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isovaleric acidemia</p>\n</td>\n<td>\n<p>Isovaleryl CoA dehydrogenase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Histidinemia</p>\n</td>\n<td>\n<p>Histidase</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperprolinemia type I</p>\n</td>\n<td>\n<p>Proline oxidase</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7011",
      "difficulty": "medium"
    },
    {
      "text": "Which micronutrient is most likely deficient in a patient with the radiographic findings given below along with anemia, neutropenia, depigmented hair and skin?",
      "choices": [
        {
          "id": 1,
          "text": "Iron"
        },
        {
          "id": 2,
          "text": "Zinc"
        },
        {
          "id": 3,
          "text": "Copper"
        },
        {
          "id": 4,
          "text": "Fluoride"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical features of <strong>anaemia </strong>and <strong>neutropenia</strong>, along with<strong> depigmented hair and skin</strong> and the radiological findings suggestive of <strong>pelkan spurs</strong>, <strong>trummerfeld zone</strong>, <strong>Frenkel's line</strong>, and <strong>Wimberger's ring</strong> sign point to the diagnosis of <strong>Menke's disease</strong>. Patients with this condition have <strong>low serum</strong> levels of <strong>copper.</strong></p>\n<p>Menke's disease or Menke-Kinky hair syndrome is an <strong>X-linked recessive</strong> condition caused due to a mutation in the <strong>ATP7A gene</strong> on <strong>chromosome X</strong>. This causes impaired transport of dietary copper from the small intestine to the liver leading to <strong>low levels</strong> of <strong>copper-containing enzymes</strong>.</p>\n<p>The final step of collagen synthesis involves the formation of <strong>covalent cross-links</strong>. This is done by the enzyme <strong>lysyl oxidase, a copper-containing protein</strong>. This is essential for the strength and rigidity of collagen. As a result of deficiency of copper in Menkes disease, this step of collagen synthesis is affected. </p>\n<p>The patient presents with depigmented kinky hair, <strong>failure to thrive</strong>, <strong>neurodegenerative symptoms</strong> (loss of developmental milestones, truncal hypotonia, epilepsy), multiple fractures, anaemia due to ceruloplasmin and hephaestin deficiency (converts ferrous to ferric to be bound to transferrin), neutropenia, and recurrent infections.</p>\n<p>Lab investigations show <strong>low serum copper </strong>(&lt;65 μg/dL) and <strong>low ceruloplasmin</strong>(&lt;20 mg/dl). The disease is <strong>fatal </strong>and has no curative treatment.</p>\n<p>A variety of distinct anomalies that are representative of <strong>scurvy</strong> and <strong>acquired copper insufficiency</strong> can be seen on radiographs of people with menke's disease.</p>\n<p>These include</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3770e97e39894e25b479b174cbb2aaeex630x557.JPEG\" alt=\"Explanation Image\"><p> </p>\n<p>Early administration of <strong>L-histidine </strong>and<strong> copper chloride</strong> injections may be beneficial.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Iron </strong>deficiency causes <strong>iron deficiency anemia</strong>, and <strong>hair loss</strong> (telogen effluvium. It does not cause neutropenia, depigmentation of hair and skin, or bony abnormalities.</p>\n<p>Option B: <strong>Zinc</strong> deficiency causes <strong>acrodermatitis enteropathica</strong> characterized by periorificial dermatitis, diarrhea, and alopecia.</p>\n<p>Option D: <strong>Fluoride</strong> is essential for bone and teeth mineralization and its deficiency causes decreased bone-mineral density, <strong>osteoporosis,</strong> and tooth decay.</p><hr><h3>Related Pearl: Menkes disease</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3f0c58fe358940b393c96afe12ef3455x1280x1951.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Synthesis of collagen and its disorders</h3><table>\n<tbody>\n<tr>\n<td>1. Collagen backbone</td>\n<td>Preprocollagen - Glycin-proline-lysine</td>\n</tr>\n<tr>\n<td>2. Hydroxylation</td>\n<td>\n<p>Of proline and lysine in the presence of Vit C.</p>\n<p>Deficiency of Vit C causes <strong>Scurvy.</strong></p>\n</td>\n</tr>\n<tr>\n<td>3. Glycosylation</td>\n<td>Formation of procollagen and resulting triple helix</td>\n</tr>\n<tr>\n<td>4. Cleavage of terminals of procollagen</td>\n<td>Resulting in the formation of tropocollagen</td>\n</tr>\n<tr>\n<td>5. Cross-linking by lysyl oxidase (copper-containing enzyme)</td>\n<td>\n<p>Formation of mature collagen.</p>\n<p>Defect causes <strong>Menkes disease</strong> and <strong>Ehlers-Danlos syndrome</strong>)</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/30549d4b95bd41e29ff34f3527796d9b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7007",
      "difficulty": "medium"
    },
    {
      "text": "A child presented with recurrent abdominal pain, vomiting, and diarrhea following ingestion of milk-based products. Which enzyme is likely to be deficient? ",
      "choices": [
        {
          "id": 1,
          "text": "Lipase"
        },
        {
          "id": 2,
          "text": "Maltase"
        },
        {
          "id": 3,
          "text": "Amylase"
        },
        {
          "id": 4,
          "text": "Lactase"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given scenario indicates intolerance of <strong>milk-based</strong> products in this child, hence, the enzyme likely to be deficient is <strong>lactase.</strong></p>\n<p>Lactase is the enzyme that is responsible for breaking down <strong>lactose</strong>, a <strong>disaccharide</strong> found in milk and dairy products. When this enzyme is deficient, it can lead to the accumulation of lactose in the intestinal lumen where it is <strong>fermented by intestinal bacteria</strong> to <strong>lactate</strong> which produces symptoms of lactose intolerance, including recurrent abdominal pain, vomiting, and diarrhea after consuming lactose-rich food items. Lactase and maltase are present in the intestinal brush border.</p>\n<p>Other options:</p>\n<p>Option A- <strong>Lipases</strong> are involved in the hydrolysis of <strong>dietary triglycerides</strong> to free fatty acids and glycerol. It is deficient in <strong>exocrine pancreatic deficiency </strong>states such as chronic pancreatitis, cystic fibrosis, and Crohn's. Although it might also present with abdominal pain and diarrhea, the stools are foul-smelling(due to gut bacteria) and greasy due to the presence of fat (<strong>steatorrhea</strong>) and are also associated with <strong>fat-soluble vitamin deficiency</strong>.</p>\n<p>Option B- <strong>Maltase</strong> breaks down <strong>maltose</strong> which is a disaccharide intermediate of starch breakdown.</p>\n<p>Option C-<strong> Amylase</strong> hydrolyses<strong> starch</strong> which is a glucose homopolymer and is present in germinating cereals, potatoes, legumes, and malt.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG7004",
      "difficulty": "easy"
    },
    {
      "text": "In the given Lineweaver-Burk plot, the blue line represents the action of an enzyme, and the red line represents the action of the same enzyme in the presence of an inhibitor.  What is the type of inhibition shown here?",
      "choices": [
        {
          "id": 1,
          "text": "Competitive inhibition"
        },
        {
          "id": 2,
          "text": "Non-competitive inhibition"
        },
        {
          "id": 3,
          "text": "Uncompetitive inhibition"
        },
        {
          "id": 4,
          "text": "Allosteric inhibition"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given graph shows <strong>competitive inhibition</strong>,<strong> </strong>in which the value of V<sub>max</sub> remains constant and the K<sub>m</sub> value increases. The intercept on the y-axis remains unchanged while the intercept on the x-axis shifts close to zero forming a steeper slope.</p>\n<p><strong>Competitive inhibition </strong>is when the inhibitor binds <strong>reversibly</strong> to the substrate-binding site and competes with the substrate for the active enzyme-binding site. This effect of competitive inhibition can be overcome <strong>by increasing</strong> the <strong>substrate concentration</strong> by which maximum velocity can still be achieved. Therefore, <strong>V<sub>max</sub></strong> (maximum velocity of the reaction) is <strong>unaltered</strong> in this type of inhibition. However, the concentration of the substrate required to achieve half of the maximum velocity is increased. Therefore, <strong>K<sub>m</sub></strong> is <strong>increased</strong> in this condition.</p>\n<p>The graph below shows the changes in Vmax and Km in competitive inhibition.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ffd327a25fb045959c699d4ffb05e602x1280x2235.JPEG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option B:<strong> Non-competitive inhibition </strong>is by binding inhibitors to enzymes in <strong>locations remote</strong> from the active site. <strong>Increasing</strong> the<strong> concentration</strong> of the substrate <strong>does not overcome</strong> non-competitive inhibition. Thus, noncompetitive inhibitors <strong>decrease the V<sub>max</sub> of the reaction</strong>. They do not interfere with the binding of the substrate to the enzyme. Thus, the enzyme shows the<strong> same K<sub>m</sub></strong> in the presence or absence of noncompetitive inhibitors.</p>\n<div class=\"ng-scope\">The graph shows the changes in V<sub>max</sub> and K<sub>m</sub> in non-competitive inhibition.</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7810bbf695664063b9db9500778f3296x1280x2317.JPEG\" alt=\"Explanation Image\"><p>Option C: In<strong> uncompetitive inhibition, </strong>inhibitors bind with the enzyme-substrate <strong>intermediate complex</strong>, and inhibit it. This leads to a decrease in both Vmax and Km. An example is the inhibition of <strong>placental</strong> alkaline phosphate (<strong>ALP</strong>) by <strong>phenylalanine</strong>. </p>\n<p>Option D: In <strong>Allosteric inhibition,</strong> inhibitors bind to a site other than the active site i.e. <strong>allosteric site</strong>, and induce a <strong>conformational change</strong> (change in the shape of the active site unlike in non-competitive inhibition) thus, inhibiting the enzyme. <strong>ATP</strong> is an allosteric inhibitor of <strong>Phosphofructokinase</strong> in glycolysis.</p><hr><h3>Related Pearl: Difference between Competitive & Non-Competitive inhibitors</h3><p>Reversible inhibitors are of two types:</p>\n<ul>\n<li>Competitive inhibitors</li>\n<li>Non-Competitive inhibitors</li>\n</ul>\n<p>Difference between Competitive &amp; Non-Competitive inhibitors</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Competitive inhibitors</strong></p>\n</td>\n<td>\n<p><strong>Non-Competitive inhibitors</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Succinate dehydrogenase is inhibited by Malonate</p>\n</td>\n<td>\n<p>Pyruvate kinase is inhibited by alanine</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Substrate &amp; inhibitor are chemically similar &amp; have same shape</p>\n</td>\n<td>\n<p>Substrate &amp; inhibitor are chemically not similar &amp; have different shape</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor binds to active site</p>\n</td>\n<td>\n<p>Inhibitor binds away from active site, i.e., at allosteric site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Inhibitor does not change the shape of the active site</p>\n</td>\n<td>\n<p>Inhibitor changes the shape of the active site</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Increase in substrate concentration reduces the inhibition</p>\n</td>\n<td>\n<p>Increase in substrate concentration does not affect the inhibition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vmax remains constant</p>\n</td>\n<td>\n<p>Vmax decreases</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Km Increases</p>\n</td>\n<td>\n<p>Km remains constant</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9dddf28550ee4318a921cb57fb032a01.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6992",
      "difficulty": "easy"
    }
  ]
}